In this randomized controlled trial, among patients with severe, uncontrolled chronic rhinosinusitis with nasal polyps, tezepelumab more effectively reduced nasal polyp size and sinonasal symptoms ...

Tezepelumab was linked to significantly reduced nasal polyp size and nasal congestion vs placebo in adults with severe CRSwNP.

Learn the essential facts about fungal sinus infections, from recognizing early warning signs to understanding treatment ...

SAN DIEGO — Among patients with previous sinus surgery for chronic rhinosinusitis with nasal polyps, the number of past surgeries did not alter the benefits of mepolizumab on nasal polyp and VAS ...

A decision to proceed with nasal polyp surgery was recorded in just 0.5% of tezepelumab-treated patients compared to 22.1% in the placebo group (hazard ratio, 0.02). Systemic glucocorticoid use ...

Standard care for CRSwNP consists of corticosteroids in the nose, after surgery and systemic corticosteroids ... and 25% to 30% of them develop nasal polyps as a result. Sanofi and Regeneron ...

significantly reducing nasal polyp size, nasal congestion severity, and the need for systemic corticosteroids and/or surgery. Rapid take-up of Dupixent in atopic dermatitis and asthma caused sales ...

A new CT-scan based risk score facilitates the identification of patients at risk of revision endoscopic sinus surgery due to chronic rhinosinusitis.

Researchers at Columbus-based Ohio State University have designed and developed the world’s first noninvasive devices aimed ...

and sometimes surgery. Treatment can help most people relieve their symptoms. Healthcare providers may classify chronic rhinosinusitis based on whether or not you have nasal polyps (soft tissue ...

A new CT-scan based risk score facilitates the identification of patients at risk of revision endoscopic sinus surgery due to chronic rhinosinusitis.

I recently went to A&E with a very high temperature. I had my blood taken and was told that my troponin levels are 4,000.